CIPROFLOXACIN KABI

400MG/200ML INF SOL 10X200ML

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 19.05.2020
Interruption of marketing 11.05.2020 0162180, 0059830, 0096040
Capacity/distribution reasons 18.05.2020
Interruption of marketing 30.04.2020 0162180, 0059830, 0096040
Capacity/distribution reasons 08.05.2020
Interruption of marketing 08.04.2020 0059830, 0096040
Capacity/distribution reasons 30.04.2020
Resumption of marketing 01.11.2018
Interruption of marketing 22.10.2018 0162180, 0059830, 0096040
Capacity/distribution reasons 05.11.2018
Resumption of marketing 15.02.2011
Interruption of marketing 15.02.2011 0125249, 0125255, 0053922, 0059830
Placing on the market 20.05.2010

All reports are available in the Overview.

Back to list